Disease ⇒ Cutaneous T cell lymphomas {40000604}
| Type: | Disease |
|---|---|
| Parent: | [ ] |
| Definition: | Cutaneous T cell lymphomas |
| Initialisation date: | [ ] |
|---|---|
| Other Terms: | [ ] |
| MedDra ID: | [ ] |
|---|---|
| MedDra Level: | [ ] |
| ICD: | [ ] |
| Category: | [ ] |
| Zone: | [ ] |
| Mechanism: | [ ] |
Notes:
[ ]
Shared Reference Notes
- [1.1] [#Staphylococcus aureus] [#Bacteriophage]
- #Endolysin strongly inhibits proliferation of S. aureus isolated from CTCL skin and significantly decreases S. aureus bacterial cell counts in a dose-dependent manner. - #Endolysin inhibits the patient-derived S. aureus induction of Interferon-gamma (IFNγ) and IFNγ-inducible chemokine CXCL10 in healthy skin. - #Endolysin strongly inhibits the effects of S. aureus on activation (reduced CD25 and STAT5 phosphorylation) and proliferation (reduced Ki67) of malignant T cells and cell lines in the presence of non-malignant T cells.
References Notes
[ ]